SCHEMBL41240

SCHEMBL41240

CCCn1ccc(=O)[nH]c1=S

nearest known ligand 0.47

Predicted protein targets (top 5)

geneUniProtsupporting neighboursconfidence
PKM P14618 1/20 0.42
CRBN Q96SW2 2/20 0.42
DUT P33316 4/20 0.39
L3MBTL1 Q9Y468 1/20 0.36
KDM1A O60341 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11546247 0.89 DUT (0.41) PKMCRBNDUT
SCHEMBL16671885 0.88 HTT (0.41) PKMCRBNDUT
Glycine SCHEMBL2322499 0.88 DUT (0.39) PKMCRBNDUT
SCHEMBL11580831 0.86 GPR84 (0.41) DUT
SCHEMBL8653850 0.86 GPR84 (0.41) DUT
SCHEMBL8656960 0.85 PKM (0.45) PKMCRBNDUTL3MBTL1
SCHEMBL11583672 0.82 PKM (0.44) PKMCRBNDUTL3MBTL1
SCHEMBL23323360 0.81 CRBN (0.38) PKMCRBNDUTL3MBTL1
SCHEMBL11581000 0.81 ALDH1A1 (0.43) PKMCRBNDUTL3MBTL1
SCHEMBL15455782 0.81 ADORA2A (0.38) DUTL3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Appears in 14865 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-122074448-A Progressive pathological animal model for drug evaluation and construction method thereof 2026-05-26 CN claimed
CN-119237105-B Recovery processing equipment of propylthiouracil 精华制药集团南通有限公司 2026-05-15 CN claimed
WO-2026100654-A1 NUCLEIC ACID INTRODUCTION AID, NUCLEIC ACID INTRODUCTION AGENT, AND NUCLEIC ACID INTRODUCTION METHOD 株式会社インファーマシア 2026-05-15 WO claimed
CN-224221364-U Propoxopyrimidine intermediate synthesis device 精华制药集团南通有限公司 2026-05-12 CN claimed
WO-2026087745-A1 AN ANTIOXIDANT COMPOSITION COMPRISING A CINNAMIC ACID DERIVATIVE BRAIN Biotech AG (DE) 2026-04-30 WO claimed
EP-4732825-A1 AN ANTIOXIDANT COMPOSITION COMPRISING A CINNAMIC ACID DERIVATIVE BRAIN Biotech AG (DE) 2026-04-29 EP claimed
US-20250255833-A1 Compositions Comprising One or More (Bio)-Alkanediols with Antioxidants SYMRISE AG (DE) 2025-08-14 US claimed
US-20250221995-A1 FATTY LIVER DISEASE TREATMENT USING GLUCOCORTICOID AND MINERALOCORTICOID RECEPTOR ANTAGONISTS CORCEPT THERAPEUTICS, INC. (US) 2025-07-10 US claimed
EP-4580594-A1 ANTIOXIDANT COMPOSITION COMPRISING 5-DEOXYFLAVONOIDS AnalytiCon Discovery - Zweigniederlassung der BRAIN Biotech AG (DE) 2025-07-09 EP claimed
EP-4565194-A1 ODOR AND COLORANT STABILIZED COMPOSITIONS Symrise AG (DE) 2025-06-11 EP claimed
WO-1995005852-A1 AGENT AGAINST SENSITIVE, HYPERREACTIVE AND HYPOACTIVE STATES OF THE SKIN, FORMS OF ACNE, ATOPIC DERMATITIDES, PSORIASIS, PRURIGO, PHOTODERMATOSES, ICHTHYOSIS AND VIRAL INFECTIONS BEIERSDORF AG (DE) 1995-03-02 WO claimed
WO-1994028897-A2 USE OF AN MHC CLASS I SUPPRESSOR DRUG FOR THE TREATMENT OF AUTOIMMUNE DISEASES AND TRANSPLANTATION REJECTION THE GOVERNMENT OF THE UNITED STATES OF AMERICA, REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) 1994-12-22 WO claimed
WO-1994023700-A1 HIGH RELEASE SOLID PREPARATION, PREPARATION AND USE THEREOF RIJKSUNIVERSITEIT GENT LABORATORIUM VOOR FARMACEUTISCHE TECHNOLOGIE (BE) 1994-10-27 WO claimed
WO-1994012183-A1 USE OF THIOURELEYLENES AND THIABENDAZOLE IN AUTOIMMUNE DISEASES ELIAS ALAN N (US) 1994-06-09 WO claimed
US-5310742-A Uses for thioureylenes ELIAS ALAN N (US) 1994-05-10 US claimed
CN-1085079-A Antithyroid cream for external application CHEN LING (CN) 1994-04-13 CN claimed
CN-1084078-A Antithyroid cream for external application CHEN LING (CN) 1994-03-23 CN claimed
WO-1993008801-A1 PREVENTION OF DRUG-INDUCED AGRANULOCYTOSIS WITH FREE RADICAL SCAVENGERS THE GOVERNMENT OF THE UNITED STATES OF AMERICA AS REPRESENTED BY THE DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) 1993-05-13 WO claimed
US-4952402-A EDIBLE TASTE-MASKED DRUGS; MICROMATRIX ACTIVE MATERIAL COATED WITH NONTOXIC POLYMER; LIQUIDS; TABLETS ELAN CORPORATION, P.L.C. (IE) 1990-08-28 US claimed
US-4369172-A Prolonged release therapeutic compositions based on hydroxypropylmethylcellulose FOREST LABORATORIES INC. (US) 1983-01-18 US claimed